Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/23 20:02 | 11/10/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Epstein David R | WA | DO | CEO | 1 | S | -2,262 | 213.01 | 0 | -11 | 137 | D | |||||||||||||||
11/13/23 19:32 | 11/9/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Himes Vaughn B | WA | O | Chief Te | 5 | S.d | -4,146 | 209.23 | 0 | -20 | 173 | D | |||||||||||||||
9/22/23 19:51 | 9/21/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Dansey Roger D | WA | O | P,R,D,CM | 3 | S | -1,058 | 206.77 | 0 | -5 | 117 | D | |||||||||||||||
9/22/23 19:47 | 9/21/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Liu Jean I | WA | O | GC | 3 | S | -488 | 206.79 | 0 | -2 | 86 | D | |||||||||||||||
9/22/23 19:46 | 9/21/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Romp Charles R | WA | O | EVP,Comm | 3 | S | -214 | 206.54 | 0 | -1 | 70 | D | |||||||||||||||
9/22/23 19:45 | 9/21/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Simpson Todd E | WA | O | CFO | 3 | S | -556 | 206.78 | 0 | -3 | 131 | D | |||||||||||||||
8/29/23 18:22 | 8/28/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Welch Daniel G | WA | D | 1 | S.d | -1,030 | 209.08 | 0 | -5 | 18 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |